Fidelis director granted 6,517 RSUs in equity award
Adams Matthew J reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Adams Matthew J reported acquisition or exercise transactions in this Form 4 filing.
Fidelis Insurance Holdings Ltd director Matthew J. Adams received an equity grant of 6,517 common shares in the form of restricted share units. The grant was made at no cash cost per share and is subject to time-based vesting conditions. After this award, Adams directly holds 22,548 common shares, including the new RSUs, each representing a contingent right to receive one common share upon vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 6,517 | $0.00 | $0.00 |
Footnotes (1)
- F1. Includes 6,517 restricted share units ("RSUs") subject to time-based vesting conditions. Each RSU represents a contingent right to receive one common share upon vesting.
Key Figures
Key Terms
time-based vesting conditions financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did FIHL director Matthew J. Adams report?
Are the 6,517 Fidelis Insurance RSUs owned outright by Matthew J. Adams?
AI-generated analysis. How Rhea-AI works. Not financial advice.